Jessica Briggs, MD
Infectious Disease · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 13 years
- Johns Hopkins University School of Medicine, 2013
Offices
1 location · University of California Sfgh Medical Group · 566 clinicians in this group
Hospitals listed: Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Briggs’s office at (628) 206-4774 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.538 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 667 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.76 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.34 (147.34 to 243.34) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 261 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,351 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.5) · 4,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.19 to 0.59) · 4,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.11 to 6.56) · 795 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.33 to 4.38) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0.25 to 17.64) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6 (2.01 to 9.98) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 167 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0.08 to 1.49) · 4,129 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.769 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 227 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 75.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8.3 to 15.1) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.9) · 966 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 88 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,644 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$3,871
Medicare paid this office $3,871 for 18 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
18 Original Medicare patients in 2024. Average age 70 · Also on Medicaid 100% · Health risk score 5.37. Sicker patients than 9 in 10 peers; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Chronic kidney disease 67% · Diabetes 61%.
The office billed $20,653, Medicare allowed $4,850 and paid $3,871; for 44 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 18 | 44 | 70 | 5.37 | $20,653 | $3,871 |
| 2023 | 11 | 24 | 62 | 4.21 | $13,583 | $2,604 |
| 2022 | 19 | 36 | 69 | 3.15 | $16,892 | $3,141 |
| 2021 | 15 | 29 | 72 | 1.84 | $17,216 | $2,969 |
| 2020 | 23 | 32 | 70 | 3.32 | $18,594 | $3,033 |
| 2019 | 35 | 65 | 66 | 2.86 | $40,643 | $6,846 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,685 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,030 | $64 |
Medicaid work
$614 in 2024
Medicaid paid $614 for 27 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $614 |
| 2024 | 27 | 1 | 15 | $614 |
| 2019 | 21 | 1 | 13 | $407 |
See the largest Medicaid services in earlier years
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 21 | $407 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 16 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 16 | None | 0% (0) | 81% | $231,240 |
| 2021 | 99 | None | 0% (0) | 51% | $139,728 |
| 2020 | 346 | 17 | None | 45% | $400,022 |
| 2019 | 334 | 20 | 3% (11) | 51% | $293,438 |
| 2018 | 209 | 14 | None | 54% | $195,478 |
| 2017 | 14 | None | 0% (0) | None | $14,798 |
| 2016 | 310 | 61 | None | 20% | $10,272 |
| 2015 | 916 | 196 | 8% (71) | 22% | $44,287 |
| 2014 | 578 | 100 | 7% (40) | None | $45,311 |
| 2013 | 208 | 27 | 6% (12) | None | $16,417 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 4 drugs
| Triumeq | 12 | $37,852 | $3,154 |
| Descovy | 13 | $25,155 | $1,935 |
| Tivicay | 12 | $23,117 | $1,926 |
| Tadalafil | 11 | $2,856 | $260 |
2020: 11 drugs
| Triumeq | 46 | $141,141 | $3,068 |
| Descovy | 32 | $59,523 | $1,860 |
| Tivicay | 32 | $59,012 | $1,844 |
| Tadalafil | 13 | $3,456 | $266 |
| Valacyclovir | 14 | $469 | $34 |
| Gabapentin | 18 | $160 | $9 |
| Propranolol | 13 | $137 | $11 |
| Paroxetine | 13 | $50 | $4 |
| Amlodipine Besylate | 17 | $37 | $2 |
| Spironolactone | 13 | $32 | $2 |
| Hydrochlorothiazide | 13 | $25 | $2 |
2019: 7 drugs
| Triumeq | 45 | $132,979 | $2,955 |
| Tivicay | 32 | $54,972 | $1,718 |
| Descovy | 30 | $51,225 | $1,708 |
| Valacyclovir | 14 | $600 | $43 |
| Gabapentin | 26 | $347 | $13 |
| Morphine Sulfate Er | 11 | $318 | $29 |
| Pravastatin | 12 | $52 | $4 |
2018: 5 drugs
| Triumeq | 29 | $81,111 | $2,797 |
| Descovy | 27 | $47,154 | $1,746 |
| Tivicay | 27 | $46,642 | $1,727 |
| Advair Diskus | 12 | $6,306 | $526 |
| Metformin | 11 | $23 | $2 |
2016: 6 drugs
| Lisinopril | 32 | $116 | $4 |
| Omeprazole | 17 | $111 | $7 |
| Atorvastatin | 12 | $97 | $8 |
| Ranitidine | 11 | $79 | $7 |
| Furosemide | 16 | $45 | $3 |
| Hydrochlorothiazide | 18 | $34 | $2 |
2015: 21 drugs
| Lantus Solostar | 11 | $4,113 | $374 |
| Metoprolol | 46 | $1,379 | $30 |
| Nifedipine Er | 28 | $1,103 | $39 |
| Oxycodone | 26 | $760 | $29 |
| Levothyroxine | 29 | $491 | $17 |
| Atorvastatin | 39 | $471 | $12 |
| Lisinopril | 78 | $408 | $5 |
| Pantoprazole | 29 | $288 | $10 |
| Metformin | 35 | $185 | $5 |
| Tramadol | 32 | $182 | $6 |
| Carvedilol | 24 | $176 | $7 |
| Furosemide | 36 | $153 | $4 |
| Gabapentin | 11 | $122 | $11 |
| Omeprazole | 13 | $113 | $9 |
| Simvastatin | 17 | $106 | $6 |
| Amlodipine Besylate | 25 | $101 | $4 |
| Clopidogrel | 12 | $97 | $8 |
| Ranitidine | 11 | $90 | $8 |
| Hydrochlorothiazide | 30 | $79 | $3 |
| Lisinopril-Hydrochlorothiazide | 15 | $78 | $5 |
| Spironolactone | 11 | $49 | $4 |
2014: 14 drugs
| Lantus Solostar | 13 | $4,408 | $339 |
| Novolog | 16 | $4,302 | $269 |
| Spiriva | 11 | $3,212 | $292 |
| Flovent Hfa | 11 | $2,067 | $188 |
| Oxycodone | 27 | $653 | $24 |
| Metoprolol | 23 | $585 | $25 |
| Gabapentin | 24 | $474 | $20 |
| Atorvastatin | 27 | $361 | $13 |
| Lisinopril | 56 | $301 | $5 |
| Warfarin | 15 | $162 | $11 |
| Amlodipine Besylate | 12 | $94 | $8 |
| Metformin | 19 | $93 | $5 |
| Furosemide | 13 | $50 | $4 |
| Hydrochlorothiazide | 14 | $45 | $3 |
2013: 3 drugs
| Lisinopril | 19 | $81 | $4 |
| Warfarin | 11 | $75 | $7 |
| Furosemide | 11 | $67 | $6 |
Money from drug and device companies
$99 in 2019
A payment is not proof that care is biased.
| Astellas Pharma US | None | $99 | 1 payment
|
See the published payment
| Astellas Pharma US | Education · 2019-01-11 | None | $99 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689977472
- Licence
- MD 9158
- Trained
- Johns Hopkins University School of Medicine, 2013 · 13 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- Po Box 743749, Los Angeles, CA, 90074
- NPI first listed
- 2010-12-16
- NPI last updated
- 2026-04-07
- NPI record certified
- 2026-04-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 600 N Wolfe St, Baltimore, MD, 21287